Kevin Charles Gorman, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 245,088 shares at $154.33 ($37.8M) on 2026-05-19, disclosed to the SEC on 2026-05-21.
Scheduled sale ($37.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XNCR | SELL | 2025-06-16 | $29K | — | Filing → |
| NBIX | SELL | 2025-05-29 | $2.3M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $1.4M | — | Filing → |